Icon Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$463K Sell
836
-3,083
-79% -$1.98M 0.03% 265
2025
Q4
$2.65M Sell
3,919
-161
-4% -$110K 0.18% 89
2025
Q3
$2.61M Sell
4,080
-873
-18% -$530K 0.18% 89
2025
Q2
$2.66M Buy
4,953
+4,378
+761% +$2.09M 0.19% 89
2025
Q1
$241K Buy
575
+41
+8% +$17.8K 0.02% 317
2024
Q4
$221K Buy
534
+11
+2% +$4.83K 0.02% 355
2024
Q3
$264K Buy
+523
New +$254K 0.02% 310
2024
Q2
Sell
-362
Closed -$195K 467
2024
Q1
$195K Hold
362
0.02% 341
2023
Q4
$201K Buy
+362
New +$170K 0.02% 322

Other funds holding IDXX

Icon Wealth Advisors's IDXX Position: Q1 2026 in Review

Icon Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 79% in Q1 2026, selling an estimated $1.98M and leaving 836 shares worth $463K. The position accounts for 0.03% of the portfolio, ranked #265.

Icon Wealth Advisors first reported a position in IDXX in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.66M in Q2 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Icon Wealth Advisors held 836 shares of Idexx Laboratories worth $463K as of Q1 2026.
  • Icon Wealth Advisors sold 3,083 Idexx Laboratories shares in Q1 2026, an estimated $1.98M.
  • Idexx Laboratories made up 0.03% of Icon Wealth Advisors's portfolio in Q1 2026, its #265 holding.
  • Icon Wealth Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 9 quarters since.
  • Icon Wealth Advisors's Idexx Laboratories position peaked at $2.66M in Q2 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Icon Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.